BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Derycz Scientific (DYSE) Spotlighted in May Issue of Pharmaceutical Representative Magazine


6/8/2010 11:05:25 AM

SANTA MONICA, Calif., June 8 /PRNewswire-FirstCall/ -- Derycz Scientific, Inc. (OTC Bulletin Board: DYSC), a company that is pioneering a fresh way of facilitating the flow of information from content publishers to enterprise customers and their constituents, is spotlighted in the May issue of Pharmaceutical Representative magazine in an article written by Derycz Scientific chairman and CEO Peter Derycz.

In the article, titled "Read Up," Mr. Derycz notes that pharmaceutical sales representatives who wish to enhance their careers and forge better relationships with their doctors can do so by harnessing new and innovative ways of procuring and sharing information about the products they sell. Specifically, sales representatives who offer value-added interactions will succeed at securing the satisfaction levels of the physicians they visit.

"You need to offer value - both to physicians and their staff - by providing them with the best and most recent information about your products," Mr. Derycz writes in the article. "In the age of technology, it has become more important than ever for the rep to go above and beyond with physicians. Although many reps do not have a technical background, enough information can be gleaned from reading peer-reviewed papers to make this a worthwhile endeavor, and one guaranteed both to impress one's physicians and to offer them information that they might not have learned on their own."

Mr. Derycz goes on to explain the roadblocks to this process, which include locating and downloading the full text of research papers and navigating various copyright issues, and how a company such as Reprints Desk can access these medical publishers' archives plus a variety of print sources, including government and academic libraries while navigating copyright issues.

To read the entire article online, please visit http://pharmrep.findpharma.com.

About Pharmaceutical Representative

For 40 years, Pharmaceutical Representativehas been a unique educational resource for pharmaceutical and biotechnology companies. Each month, the magazine provides sales training, clinical education and industry analysis for an audience of more than 30,000 reps, trainers and sales managers. The magazine provides insight into emerging industry trends as well as practical tips for improving sales performance so that pharmaceutical and biotechnology representatives are better equipped to succeed.

About Derycz Scientific®

Derycz Scientific, Inc. (the "Company") develops companies, products, services and systems that facilitate the re-use of published content in a manner that helps organizations achieve their marketing, communication and research goals effectively and in compliance with copyright law and regulatory rules. Its subsidiary companies include Reprints Desk and Pools Press. Reprints Desk offers a one-stop solution for reprints, ePrints and single articles, and has delivered millions of articles worldwide. Reprint Desk is an innovator in content retrieval and ePrint delivery and its services are designed to help make effective use of published articles in a copyright-compliant manner. Pools Press has excelled in the reprint market for over 30 years. It provides professionally printed articles from medical and technical journals; prints booklets, catalogs, pamphlets, direct mail pieces, newsletters, and all business stationery; and works with publishers who wish to outsource a portion of or all of their reprints business. For more information, go to www.deryczscientific.com.

About Reprints Desk®

Reprints Desk, Inc., is a business software and information services company that simplifies how research-intensive companies and other organizations procure, manage and share journal articles and other copyright-protected content. The company's content workflow and compliance solutions help customers effectively use peer-reviewed literature in research, regulatory submissions, and product promotions. A channel supplier for more than 100 scientific, technical, and medical (STM) publishers, Reprints Desk earned the #1 ranking in the 2008 Document Delivery Vendor Scorecard by Outsell, Inc., and currently serves companies in life sciences, energy, aerospace, industrial products, food and beverages, consumer packaged goods, information technology, legal, academia, and government. Reprints Desk is a Derycz Scientific company. For more information about Reprints Desk, go to www.reprintsdesk.com.

Forward-Looking Statements

As a cautionary note to investors, certain matters discussed in this press release may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; acceptance of the Company's products in the market; the Company's success in technology and product development; the Company's ability to execute its business model and strategic plans; and all the risks and related information described from time to time in the Company's SEC filings, including the financial statements and related information contained in the Company's SEC Filing. The Company assumes no obligation to update the information in this release.

SOURCE Derycz Scientific, Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES